Biotechnology Assets, S.A. (BME:BST)
Spain flag Spain · Delayed Price · Currency is EUR
0.2160
0.00 (0.00%)
Nov 16, 2026, 3:32 PM CET

Biotechnology Assets Income Statement

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
2.983.093.163.62.613.09
Revenue Growth
-8.29%-2.10%-12.34%37.79%-15.28%22.21%
Cost of Revenue
0.210.260.350.450.360.25
Gross Profit
2.782.832.813.152.252.84
Selling, General & Admin
2.362.442.952.962.563.33
Other Operating Expenses
-0.36-0.59-0.7-4.99-0.72-0.5
Operating Expenses
3.893.864.450.443.994.91
Operating Income
-1.11-1.03-1.652.71-1.74-2.07
Interest Expense
-0.09-0.13-0.18-0.31-0.35-0.85
Interest & Investment Income
000000
Currency Exchange Gain (Loss)
-0.06-0.06-0.05-0.020.030.01
EBT Excluding Unusual Items
-1.26-1.22-1.872.38-2.05-2.91
Asset Writedown
-0.67-0.66-1.2-0.05--
Other Unusual Items
0.030.290.0200.010
Pretax Income
-1.9-1.6-3.062.32-2.04-2.91
Income Tax Expense
0.370.32-0.140.75-0.10.1
Earnings From Continuing Operations
-2.27-1.92-2.921.57-1.94-3.01
Net Income to Company
-2.27-1.92-2.921.57-1.94-3.01
Minority Interest in Earnings
00--000
Net Income
-2.27-1.92-2.921.57-1.94-3.01
Net Income to Common
-2.27-1.92-2.921.57-1.94-3.01
Net Income Growth
------
Shares Outstanding (Basic)
75-66585446
Shares Outstanding (Diluted)
75-66585446
Shares Change
--14.28%6.50%18.82%16.39%
EPS (Basic)
-0.03--0.040.03-0.04-0.07
EPS (Diluted)
-0.03--0.040.03-0.04-0.07
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-0.66-0.02-0.09-0.02-0.14-1.52
Free Cash Flow Per Share
-0.01--0.00--0.00-0.03
Gross Margin
93.09%91.69%88.91%87.49%86.05%92.01%
Operating Margin
-37.13%-33.23%-52.13%75.19%-66.44%-67.25%
Profit Margin
-75.93%-61.99%-92.41%43.70%-74.35%-97.65%
Free Cash Flow Margin
-22.05%-0.49%-2.77%-0.61%-5.54%-49.24%
EBITDA
-0.84-0.1-0.653.72-0.71-1.04
EBITDA Margin
-28.19%-3.25%-20.60%103.35%-27.21%-33.82%
D&A For EBITDA
0.270.9311.011.031.03
EBIT
-1.11-1.03-1.652.71-1.74-2.07
EBIT Margin
-37.13%-33.23%-52.13%75.19%-66.44%-67.25%
Effective Tax Rate
---32.23%--
Advertising Expenses
-0.020.050.040.010.05